Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Other Non-Current Assets (2016 - 2025)

Standard Biotools (LAB) has disclosed Other Non-Current Assets for 16 consecutive years, with $230.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Other Non-Current Assets changed N/A to $230.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $230.7 million, a N/A change, with the full-year FY2024 number at $183.4 million, up 7927.66% from a year prior.
  • Other Non-Current Assets was $230.7 million for Q3 2025 at Standard Biotools, up from $3.7 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $230.7 million in Q3 2025 to a low of $2.3 million in Q4 2023.
  • A 5-year average of $37.4 million and a median of $3.4 million in 2022 define the central range for Other Non-Current Assets.
  • Peak YoY movement for Other Non-Current Assets: dropped 26.5% in 2023, then skyrocketed 7927.66% in 2024.
  • Standard Biotools' Other Non-Current Assets stood at $3.7 million in 2021, then fell by 15.72% to $3.1 million in 2022, then decreased by 26.5% to $2.3 million in 2023, then surged by 7927.66% to $183.4 million in 2024, then grew by 25.76% to $230.7 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Other Non-Current Assets are $230.7 million (Q3 2025), $3.7 million (Q2 2025), and $6.5 million (Q1 2025).